Fig. 5From: Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 miceEffect of rHDL-rApoJ nanodiscs or free rApoJ treatment on circulating Aβ levels. a CSF levels of Aβ40 detected by ELISA. b Plasmatic Aβ40 levels detected by ELISA. c Expression of Aβ-transporting receptors (LRP-1 and RAGE) determined by Western blot. Data are expressed as the mean ± SEM. N = 5–7 group. *p < 0.05; **p < 0.01Back to article page